Cargando…
N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
The search for novel anticancer therapeutics with the ability to overcome multi-drug resistance (MDR) mechanisms is of high priority. A class of molecules that show potential in overcoming MDR are the N-alkylated isatins. In particular 5,7-dibromo-N-alkylisatins are potent microtubule destabilizing...
Autores principales: | Vine, Kara L., Belfiore, Lisa, Jones, Luke, Locke, Julie M., Wade, Samantha, Minaei, Elahe, Ranson, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945850/ https://www.ncbi.nlm.nih.gov/pubmed/27441242 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 |
Ejemplares similares
-
N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages
por: Sluyter, Ronald, et al.
Publicado: (2016) -
Simple and Efficient Microwave Assisted N-Alkylation of Isatin
por: Shmidt, María Sol, et al.
Publicado: (2008) -
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens
por: Al-Warhi, Tarfah, et al.
Publicado: (2022) -
N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
por: Belfiore, Lisa, et al.
Publicado: (2020) -
Isothiourea-Catalyzed
[2 + 2] Cycloaddition of C(1)-Ammonium
Enolates and N-Alkyl Isatins
por: Abdelhamid, Yusra, et al.
Publicado: (2022)